4-toluenesulfonyl chloride has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gan, X; Li, S; Ma, A; Wang, P; Wu, B; Wu, Z; Xu, R; Xu, Y; Yang, L; Yu, Q | 1 |
1 other study(ies) available for 4-toluenesulfonyl chloride and Leukemia
| Article | Year |
|---|---|
Novel synthetic tosyl chloride-berbamine regresses lethal MYC-positive leukemia by targeting CaMKIIγ/Myc axis.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Leukemic; Humans; Inhibitory Concentration 50; Leukemia; Mice; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc; RNA, Messenger; Signal Transduction; Tosyl Compounds; Transcription, Genetic | 2019 |